Ordinance
on Clinical Trials
with the exception of
Clinical Trials of Medical Devices1
(Clinical Trials Ordinance, ClinO)

of 20 September 2013 (Status as of 26 May 2022)

1 Amended by Annex 2 No 2 of the O of 1 July 2020 on Clinical Trials with Medical Devices, in force since 26 May 2021 (AS 2020 3033).


Open article in different language:  DE  |  FR  |  IT
Art. 23 Coordination and information in authorisation procedures

1 The in­vest­ig­at­or and the spon­sor may sim­ul­tan­eously sub­mit ap­plic­a­tions to the re­spons­ible eth­ics com­mit­tee and to the Agency.

2 The re­spons­ible eth­ics com­mit­tee and the Agency shall in­form each oth­er about mat­ters re­lat­ing to the re­view areas spe­cified in Art­icle 25 and in Art­icle 32, and shall co­ordin­ate their as­sess­ments.

Diese Seite ist durch reCAPTCHA geschützt und die Google Datenschutzrichtlinie und Nutzungsbedingungen gelten.

Feedback
Laden